Picture of Eris Lifesciences logo

ERIS — Eris Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

India's Eris rises on buying 9 dermatology brands

** Shares of Indian drugmaker Eris Lifesciences Ltd
 ERIS.NS  rise as much as 3.4% to 605.6 rupees
    ** Stock set to snap six straight sessions of losses if
gains hold
    ** Co buys nine dermatology brands from Dr. Reddy's
Laboratories  REDY.NS  for 2.75 billion rupees ($33.31 million)
    ** Acquisition to strengthen co's presence in fast-growing
cosmetic dermatology segment- Nirmal Bang analysts
    ** While deal will expand dermatology offerings of ERIS,
brokerage Prabhudas Lilladher sees it as diluting earnings per
share (EPS) in near term     
    ** Stock trading below 50-day, 100-day and 200-day simple
moving avgs
    ** More than 150,000 shares change hands by 1:27 a.m. IST,
7.2x 30-day avg of 21,008 shares
    ** All 10 analysts covering stock have a "buy" or "strong
buy" rating; median PT is 802 rupees - Refinitiv data
    ** Stock down 9.5% YTD up to last close, fell 14.8% in 2022

($1 = 82.5675 Indian rupees)

 (Reporting by Anuran Sadhu in Bengaluru)
 ((Anuran.Sadhu@thomsonreuters.com ;))

Recent news on Eris Lifesciences

See all news